AzTrials
AzTrials

OsteoarthritisNCT02544620

Out Patient Surgery for Total Knee and Hip Replacement and Unicompartmental Knee Replacement - a Feasibility Study

An observational study of Osteoarthritis, run by Kirill Gromov at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate feasibly of outpatient Total Knee Replacement, Total Hip Replacement and Unicompartmental Knee Replacement in a modern fast-track setup. The design is as an observational prospective study, evaluating patients that fulfil discharge criteria on the day of the surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoarthritis
What is being tested?
Does fulfil of discharge criteria on the day of the surgery and Does not fulfil of discharge criteria on the day of the surgery
How many people
1,000 participants
Where
1 siteDenmark
Study dates
Sep 2015to 31 Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * Unselected primary THA/TKA/UKA * ASA score I/II * Can be operated as #1 or #2 * No sleep apnea treated with CPAP

Who may be able to join

  • Unselected primary THA/TKA
  • ASA score I/II
  • Can be operated as #1 or #2
  • No sleep apnea treated with CPAP

Who cannot join

  • Selected primary THA/TKA
  • ASA score > 2
  • Cannot be operated as #1 or #2
  • Sleep apnea treated with CPAP

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Hvidovre Hospital

    Hvidovre, 2650

Other trials in Denmark

About this study

The purpose of this study is to evaluate feasibly of outpatient Total Knee Replacement, Total Hip Replacement and Unicompartmental Knee Replacement in a modern fast-track setup. The design is as an observational prospective study, evaluating patients that fulfil discharge criteria on the day of the surgery. The investigators will further evaluate safety aspects, such a early morbidity and mortality, as well as patient satisfaction.

Read the detailed description

Fast-track total hip arthroplasty (THA), total knee arthroplasty (TKA) and Unicompartmental Knee arthroplasty (UKA) with length of stay (LOS) of 1-3 is a well established concept for treating hip and knee osteoarthritis, resulting in short reconvalescence, high patient satisfaction, and an excellent safety profile (lower or similar mortality / morbidity compared to conventional pathways with longer LOS). LOS have been significantly reduced during the past decade, and several centers have published even shorter hospitals stays: <24 hours, with patients staying the night at the hospital but also outpatient surgery, with patients being discharged on the day of surgery.

However, these proposed pathways with extremely short LOS, are performed on very selected patients, with few details on patient satisfaction, outcome and most important patient safety. Therefore, it is not possible to draw conclusions on feasibility of outpatient THA, TKA and UKA surgery in a general and unselected population. Further on, there is a need for investigation of safety aspects of outpatient surgery in respect to mortality, morbidity, patient satisfaction and patient reported outcomes. As some, most likely healthy and younger, patients might benefit from outpatient surgery - eg discharge on the day of surgery, while others might not; the first step is to identify the patients that are suitable for outpatient THA and TKA surgery and investigate the safety aspects in respect to mortality, morbidity, patient satisfaction and patient reported outcomes.

Aim:

The aim of this study is to investigate "feasibility" and "safety" of outpatient THA, TKA and UKA surgery, respectively as follows:

Feasibility

  • Proportion of patients, that can be included in the study according to inclusion criteria stated below, and be evaluated for potential same-day discharge (I) (I = included)
  • Proportion of included patients (I), that are discharged on the day of surgery (U) and those who are not discharged and stay for >1 day (B)
  • Identify reasons for patients not being able to be discharged on the day of surgery (B)

Safety

  • risk for complications (morbidity) in group (U) compared to group (B) (are there complications that potentially could have been avoided is the patient was not discharged)
  • readmissions in group (U ) compared to group (B) within 90 days
  • mortality in group (U ) compared to group (B) within 90 days
  • patient satisfaction in group (U ) compared to group (B)
  • Patient reported outcome (Oxford knee score + range of motion for TKA and UKA group, and Oxford hip score for THA group) in group (U) compared to group (B)
  • contacts to primary sector in group (U ) compared to group (B) within 7 days.
  • use of rescue morphine (pain journal) for 7 days post op in group (U ) compared to group (B)
Conditions
Osteoarthritis
Being tested
Does fulfil of discharge criteria on the day of the surgery, Does not fulfil of discharge criteria on the day of the surgery
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Does fulfil of discharge criteria on the day of the surgeryOther

  • Does not fulfil of discharge criteria on the day of the surgeryOther

Study groups in NCT02544620
Study groupRoleWhat they receive
Total Hip arthroplasty* Unselected primary THA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)
Receives: Other: Does fulfil of discharge criteria on the day of the surgery; Other: Does not fulfil of discharge criteria on the day of the surgery
Total Knee arthroplasty* Unselected primary TKA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)
Receives: Other: Does fulfil of discharge criteria on the day of the surgery; Other: Does not fulfil of discharge criteria on the day of the surgery
unicompartmental knee arthroplasty* Unselected primary UKA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)
Receives: Other: Does fulfil of discharge criteria on the day of the surgery; Other: Does not fulfil of discharge criteria on the day of the surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fulfilment of same day discharge criteria

    On the days of surgery following discharge criteria are continuously evaluated:

    • < 500 ml intraoperative blood loss
    • Back in patient ward <15.00
    • Received instruction from physiotherapist and is safely mobilized
    • No clinical symptoms of anemia
    • Pain <3 while resting, <5 during exercise.
    • Spontaneous urination
    • Post op x-ray is performed and approved
    • Relatives or friends with patient for >24 hours
    • Motivated and accepts same day discharge
    • Standard discharge criteria fulfilled
    • Can be discharged before 20.00

    If all of the above criteria are fulfilled, the patient can be discharged

    Measured: 12 hours

Secondary outcomes (3)
  1. Readmissions

    Measured: 3 months

  2. Patient reported satisfaction

    OKS (Oxford Knee score) and ROM (Range og motion) for TKA and UKA, OHS for THA

    Measured: 3 months

  3. Use of rescue morphine

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2015 (estimated)
  2. Study startSep 2015
  3. Primary completion31 Aug 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02544620
Sponsor's protocol ID
HVH-SK-TKA-THA-UKA
Status last verified
Mar 2019
First submitted
6 Sep 2015
Last updated
28 Mar 2019
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoarthritis, run by Kirill Gromov at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fulfilment of same day discharge criteria (time frame: 12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in